Literature DB >> 22783381

Meningeal tumor: A rare extrahepatic association in patients with polycystic liver disease enrolled for liver transplantation.

Alexandre Bakonyi Neto1, Marco Antonio Zanini, Amanda Pinter Cavalheiro DA Silva, Camila Winckler, Rodrigo Mattos Dos Santos, Marcelo Lopes Furtado.   

Abstract

In the present study, we described a rare association of polycystic liver disease (PCLD) with intracranial meningiomas in patients included on a liver transplant list, focusing on the diagnosis, treatment and possible association with any genetic alterations. Two female patients, aged 39 and 49 years were included on a liver transplant list due to extensive PCLD, with symptoms related to an abdominal compartmental syndrome. Screening for extrahepatic manifestation revealed a right frontal meningioma in the first patient, and a parietal posterior calcified meningioma in the second patient, measuring 1 and 7×3×2 cm in diameter, respectively. Following tumor removal, the histological pattern was compatible with fibrous and transitional meningioma, respectively. Cytogenetic studies conducted following surgery did not reveal any changes in metaphase chromosomes. The postoperative follow-up for the two patients was uneventful, without complications, with the patients remaining on a liver transplant waiting list. We conclude that screening for extrahepatic manifestations of PCLD is mandatory, as certain lesions require treatment prior to liver transplantation. The lack of a genetic or familial association between these two cases show they are likely to have occurred by chance, rather than representing a previously unrecognized association between polycystic liver disease and cranial meningioma.

Entities:  

Year:  2012        PMID: 22783381      PMCID: PMC3389620          DOI: 10.3892/ol.2012.605

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families.

Authors:  Pia Tahvanainen; Esa Tahvanainen; Hanna Reijonen; Leena Halme; Helena Kääriäinen; Krister Höckerstedt
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

2.  Polycystic liver disease: new insights into disease pathogenesis.

Authors:  Tatyana Masyuk; Nicholas LaRusso
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.

Authors:  Esmé Waanders; René H M te Morsche; Rob A de Man; Jan B M J Jansen; Joost P H Drenth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

4.  Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.

Authors:  D M Reynolds; C T Falk; A Li; B F King; P S Kamath; J Huston; C Shub; D M Iglesias; R S Martin; Y Pirson; V E Torres; S Somlo
Journal:  Am J Hum Genet       Date:  2000-10-23       Impact factor: 11.025

5.  Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease.

Authors:  D J Peters; L Spruit; J J Saris; D Ravine; L A Sandkuijl; R Fossdal; J Boersma; R van Eijk; S Nørby; C D Constantinou-Deltas
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

Review 6.  Polycystic disease of the liver.

Authors:  Gregory T Everson; Matthew R G Taylor; R Brian Doctor
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 7.  Meningioma.

Authors:  Christine Marosi; Marco Hassler; Karl Roessler; Michele Reni; Milena Sant; Elena Mazza; Charles Vecht
Journal:  Crit Rev Oncol Hematol       Date:  2008-03-14       Impact factor: 6.312

8.  Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.

Authors:  R Sherstha; C McKinley; P Russ; A Scherzinger; T Bronner; R Showalter; G T Everson
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

9.  Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2.

Authors:  Y Pirson; N Lannoy; D Peters; A Geubel; J F Gigot; M Breuning; C Verellen-Dumoulin
Journal:  Hepatology       Date:  1996-02       Impact factor: 17.425

10.  PRKCSH genetic mutation was not found in Taiwanese patients with polycystic liver disease.

Authors:  An-Ming Yang; Shou-Chuan Shih; Cheng-Hsin Chu; Tsang-En Wang; Wei-Shiung Yang
Journal:  Dig Dis Sci       Date:  2009-03-24       Impact factor: 3.199

View more
  1 in total

1.  Neuroendocrine tumor in the liver of a patient with isolated polycystic liver disease: A case report and review of the literature.

Authors:  Konstantinos Koutsampasopoulos; Elisavet Antoniadou; Stavros Zoutis; Grigorios Iacovidis; Olga Burova; Antonios Taplidis
Journal:  Oncol Lett       Date:  2013-03-06       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.